Ocular manifestations of the antiphospholipid syndrome

British Journal of Ophthalmology

Volumn 95, Issue 4, 2011, Pages 454-459

  Utz, Virginia Miraldi ^a   Tang, Johnny ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTERIOR EYE SEGMENT; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BLOOD VESSEL OCCLUSION; BLURRED VISION; CLINICAL FEATURE; DRY EYE; EYE DISEASE; FETUS WASTAGE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; NEUROOPHTHALMOLOGY; OCULAR BLOOD VESSEL; OPHTHALMOSCOPY; PATHOPHYSIOLOGY; PLASMAPHERESIS; POSTERIOR EYE SEGMENT; PRIORITY JOURNAL; REVIEW; SCOTOMA; THROMBOSIS; TRANSITIONAL BLINDNESS; VASCULAR DISEASE; VEIN THROMBOSIS; VISUAL FIELD DEFECT;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; EYE DISEASES; HEMOSTASIS; HUMANS; VENOUS THROMBOSIS;

EID: 79952910076     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.182857     Document Type: Review

References (80)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
2. Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 1994;96:3-9. (Pubitemid 24043645)
3. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63. (Pubitemid 34983997)
4. Asherson RA, Merry P, Acheson JF, et al. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis 1989;48:358-61.
5. Demirci FY, Kucukkaya R, Akarcay K, et al. Ocular involvement in primary antiphospholipid syndrome. Ocular involvement in primary APS. Int Ophthalmol 1998;22:323-9.
6. Cervera R, Boffa MC, Khamashta MA, et al. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus 2009;18:889-93.
7. Castanon C, Amigo MC, Banales JL, et al. Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology 1995;102:256-62.
8. Ruiz-Irastorza G, Hunt BJ, Khamashta MA. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis Rheum 2007;57:1487-95. (Pubitemid 350308848)
9. Vila P, Hernandez MC, Lopez-Fernandez MF, et al. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994;72:209-13. (Pubitemid 24251281)
10. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000;15:145-51.
11. Giron-Gonzalez JA, Garcia del Rio E, Rodriguez C, et al. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 2004;31:1560-7. (Pubitemid 39006638)
12. Finazzi G. The Italian registry of antiphospholipid antibodies. Haematologica 1997;82:101-5. (Pubitemid 28023500)
13. Leo-Kottler B, Klein R, Berg PA, et al. Ocular symptoms in association with antiphospholipid antibodies. Graefes Arch Clin Exp Ophthalmol 1998;236:658-68. (Pubitemid 28427176)
14. Tripodi A. Testing for lupus anticoagulants: all that a clinician should know. Lupus 2009;18:291-8.
15. de Groot PG, Derksen RH. Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost 2005;3:1854-60. (Pubitemid 41716572)
16. Rovensky J. Asherson's syndrome - catastrophic antiphospholipid syndrome. Autoimmun Rev 2006;6:61-3. (Pubitemid 44810174)
17. Stojanovich L, Marisavljevic D, Rovensky J, et al. Clinical and laboratory features of the catastrophic antiphospholipid syndrome. Clin Rev Allergy Immunol 2009;36:74-9.
18. Miserocchi E, Baltatzis S, Foster CS. Ocular features associated with anticardiolipin antibodies: a descriptive study. Am J Ophthalmol 2001;131:451-6. (Pubitemid 32273431)
19. Suvajac G, Stojanovich L, Milenkovich S. Ocular manifestations in antiphospholipid syndrome. Autoimmun Rev 2007;6:409-14. (Pubitemid 46824094)
20. Asherson RA, Khamashta MA, Gil A, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989;86:391-9. (Pubitemid 19103905)
21. Yehudai D, Shoenfeld Y, Toubi E. Looking into the eyes of patients with antiphospholipid syndrome. Clin Rev Allergy Immunol 2007;32:192-7. (Pubitemid 47571446)
22. Giorgi D, David V, Afeltra A, et al. Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome. Ocul Immunol Inflamm 2001;9:49-57. (Pubitemid 32234166)
23. Gelfand YA, Dori D, Miller B, et al. Visual disturbances and pathologic ocular findings in primary antiphospholipid syndrome. Ophthalmology 1999;106:1537-40. (Pubitemid 30214353)
24. Durrani OM, Cameron-Swaby DA, Bowman S, et al. Scleritis as the presenting sign of primary antiphospholipid syndrome. Eye (Lond) 2001;15:558-9. (Pubitemid 32755739)
25. Ang LP, Lim AT, Yap EY. Central retinal vein and ophthalmic artery occlusion in primary antiphospholipid syndrome. Eye (Lond) 2004;18:439-40. (Pubitemid 38585026)
26. Levy J, Baumgarten A, Rosenthal G, et al. Consecutive central retinal artery and vein occlusions in primary antiphospholipid syndrome. Retina 2002;22:784-6. (Pubitemid 35462510)
27. Beckhauser AP, Arana LA, Skare TL. Antiphospholipid syndrome and bilateral retinal artery and vein occlusion: case report. Arq Bras Oftalmol 2008;71:282-5.
28. Sivaprasad S, Gregor Z. Hughes syndrome. Clin Experiment Ophthalmol 2007;35:496-8. (Pubitemid 47162771)
29. Trojet S, Loukil I, El Afrit MA, et al. Bilateral retinal vascular occlusion during antiphospholipid antibody syndrome: a case report. J Fr Ophtalmol 2005;28:503-7. (Pubitemid 40791455)
30. Wiechens B, Schroder JO, Potzsch B, et al. Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol 1997;123:848-50. (Pubitemid 27250939)
31. Tomasini DN, Segu B. Systemic considerations in bilateral central retinal vein occlusion. Optometry 2007;78:402-8.
32. Rumelt S, Rehany U. Central retinal artery occlusion associated with primary antiphospholipid syndrome. Eye (Lond) 1999;13:699-700. (Pubitemid 29511864)
33. Pulido JS, Ward LM, Fishman GA, et al. Antiphospholipid antibodies associated with retinal vascular disease. Retina 1987;7:215-18. (Pubitemid 18042617)
34. Dogulu CF, Kansu T, Kadayifcilar S. The role of IgM isotype anticardiolipin antibodies in occlusive ocular vascular disease: report of two cases with primary antiphospholipid antibody syndrome. Eye (Lond) 2000;5:789-90.
35. Zajdenweber ME, Muccioli C, Moraes RT, et al. Localized retinal ischemia as an ocular manifestation of primary antiphospholipid syndrome. Can J Ophthalmol 2007;42:479-80. (Pubitemid 46932050)
36. Boltin D, Boguslavski V, Sagi L, et al. Antiphospholipid syndrome presenting as unilateral renal artery occlusion: case report and literature review. Rheumatol Int 2009;29:831-5.
37. Saxonhouse MA, Bhatti MT, Driebe WT Jr, et al. Primary antiphospholipid syndrome presenting with a branch retinal artery occlusion in a 15-year-old boy. J Child Neurol 2002;17:392-4. (Pubitemid 34919133)
38. Ang LP, Yap EY, Fam HB. Bilateral choroidal infarction in a patient with antiphospholipid syndrome: a case report. Clin Experiment Ophthalmol 2000;28:326-8.
39. Snyers B, Lambert M, Hardy JP. Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies. Retina 1990;10:255-60.
40. Dori D, Gelfand YA, Brenner B, et al. Cilioretinal artery occlusion: an ocular complication of primary antiphospholipid syndrome. Retina 1997;17:555-7. (Pubitemid 28032441)
41. Jabs DA, Fine SL, Hochberg MC, et al. Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol 1986;104:558-63. (Pubitemid 16086344)
42. Boets EP, Chaar CG, Ronday K, et al. Chorioretinopathy in primary antiphospholipid syndrome: a case report. Retina 1998;18:382-5. (Pubitemid 30387116)
43. Hartnett ME, Laposata M, Van Cott E. Antiphospholipid antibody syndrome in a six-year-old female patient. Am J Ophthalmol 2003;135:542-4. (Pubitemid 36315970)
44. Vine AK. Severe periphlebitis, peripheral retinal ischemia, and preretinal neovascularization in patients with multiple sclerosis. Am J Ophthalmol 1992;113:28-32.
45. Smith JR, Chng H, Chee S. Primary antiphospholipid syndrome masquerading as diabetic retinopathy. Jpn J Ophthalmol 2001;45:105-8. (Pubitemid 32015901)
46. Tang J, Fillmore G, Nussenblatt RB. Antiphospholipid antibody syndrome mimicking serpiginous choroidopathy. Ocul Immunol Inflamm 2009;17:278-81.
47. Dunn JP, Noorily SW, Petri M, et al. Antiphospholipid antibodies and retinal vascular disease. Lupus 1996;5:313-22. (Pubitemid 26306242)
48. Kleiner RC, Najarian LV, Schatten S, et al. Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology 1989;96:896-904. (Pubitemid 19165119)
49. Curi AL, Jacks A, Pavesio C. Choroidal neovascular membrane presenting as a complication of pre-eclampsia in a patient with the antiphospholipid syndrome. Br J Ophthalmol 2000;84:1080.
50. Costen MT, Olson JA. Central serous chorioretinopathy may be a manifestation of the primary antiphospholipid syndrome. Br J Ophthalmol 2000;84:667. (Pubitemid 30339324)
51. Costen MT, Parkin BT, Davison CR, et al. Central serous chorioretinopathy and antiphospholipid antibodies-results of a pilot study. Eye (Lond) 2004;18:938. (Pubitemid 39328334)
52. Al-Abdulla NA, Thompson JT, LaBorwit SE. Simultaneous bilateral central retinal vein occlusion associated with anticardiolipin antibodies in leukemia. Am J Ophthalmol 2001;132:266-8. (Pubitemid 32706531)
53. Murphy PT, Rao P. Central retinal venous occlusion with co-existent thrombotic thrombocytopenic purpura and antiphospholipid syndrome. Br J Ophthalmol 2003;87:658-9. (Pubitemid 36535356)
54. Glacet-Bernard A, Bayani N, Chretien P, et al. Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients. Arch Ophthalmol 1994;112:790-5.
55. Giordano N, Senesi M, Battisti E, et al. Antiphospholipid antibodies in patients with retinal vascular occlusions. Acta Ophthalmol Scand 1998;76:128-9. (Pubitemid 28120618)
56. Cobo-Soriano R, Sanchez-Ramon S, Aparicio MJ, et al. Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study. Am J Ophthalmol 1999;128:725-32. (Pubitemid 30001768)
57. Bashshur ZF, Taher A, Masri AF, et al. Anticardiolipin antibodies in patients with retinal vein occlusion and no risk factors: a prospective study. Retina 2003;23:486-90. (Pubitemid 37071961)
58. Giorgi D, Gabrieli CB, Bonomo L. The clinico-ophthalmological spectrum of antiphospholipid syndrome. Ocul Immunol Inflamm 1998;6:269-73. (Pubitemid 29043750)
59. Genevay S, Hayem G, Hamza S, et al. Oculomotor palsy in six patients with systemic lupus erythematosus. A possible role of antiphospholipid syndrome. Lupus 2002;11:313-16.
60. Shin SY, Lee JM. A case of multiple cranial nerve palsies as the initial ophthalmic presentation of antiphospholipid syndrome. Korean J Ophthalmol 2006;20:76-8.
61. Giorgi D, Balacco Gabrieli C. Optic neuropathy in systemic lupus erythematosus and antiphospholipid syndrome (APS): clinical features, pathogenesis, review of the literature and proposed ophthalmological criteria for APS diagnosis. Clin Rheumatol 1999;18:124-31. (Pubitemid 29223033)
62. Srinivasan S, Fern A, Watson WH, et al. Reversal of nonarteritic anterior ischemic optic neuropathy associated with coexisting primary antiphospholipid syndrome and Factor V Leiden mutation. Am J Ophthalmol 2001;131:671-3. (Pubitemid 32422136)
63. Kremmer S, Kreuzfelder E, Bachor E, et al. Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies. Br J Ophthalmol 2004;88:1259-62. (Pubitemid 39312967)
64. Kremmer S, Kreuzfelder E, Klein R, et al. Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin Exp Immunol 2001;125:211-15. (Pubitemid 32758430)
65. Erkan D, Yazici Y, Peterson MG, et al. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 2002;41:924-9.
66. Wahl DG, Bounameaux H, de Moerloose P, et al. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Arch Intern Med 2000;160:2042-8. (Pubitemid 30437588)
67. Erkan D, Harrison MJ, Levy R, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 2007;56:2382-91. (Pubitemid 47173586)
68. Tuthill JI, Khamashta MA. Management of antiphospholipid syndrome. J Autoimmun 2009;33:92-8.
69. Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-8.
70. Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.
71. Derksen RH, de Groot PG, Kater L, et al. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993;52:689-92. (Pubitemid 23280441)
72. Levine SR, Brey RL, Tilley BC, et al. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004;291:576-84. (Pubitemid 38500311)
73. Asherson RA, Baguley E, Pal C, et al. Antiphospholipid syndrome: five year follow up. Ann Rheum Dis 1991;50:805-10.
74. Dentali F, Crowther M. Antiphospholipid antibodies in critical illness. Crit Care Med 2010:38(2 Suppl):S51-6.
75. Cervera R. Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome. Curr Rheumatol Rep 2010;12:70-6.
76. Adamson R, Sangle S, Kaul A, et al. Clinical improvement in antiphospholipid syndrome after rituximab therapy. J Clin Rheumatol 2008;14:359-60.
77. Hughes G. Rituximab in lupus and beyond: the state of the art. Lupus 2009;18:639-44.
78. Kent D, Hickey-Dwyer M, Clark D. Long-term follow-up of ischaemic retinopathy in the antiphospholipid syndrome with lupus-like disease. Eye (Lond) 2000;14:313-17. (Pubitemid 30479703)
79. Durrani OM, Gordon C, Murray PI. Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol 2002;47:215-38. (Pubitemid 34575356)
80. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006;295:1050-7.